Executive chairman sells shares worth $1.64m, signaling potential shifts in insider sentiment at the diagnostics firm.
Natera’s executive chairman sold $1.64m in company shares, according to recent filings. The transaction reflects ongoing insider activity at the molecular diagnostics firm, which has seen mixed trading patterns this quarter.
Prior insider sales at Natera totaled $3.2m over the past three months, with no reported purchases. The company’s stock has fluctuated between $45 and $60 during the same period, underperforming broader biotech indices.
Markets showed limited reaction to the filing, with Natera shares trading flat in after-hours activity.